He, Guohua
Tao, Liyuan
Li, Chenglong
Zhong, Xuhui
Wang, Haibo
Ding, Jie
Funding for this research was provided by:
Beijing Natural Science Foundation (Z190023)
the Capital Characteristic Clinical Application Research supported by Beijing Municipal Science & Technology Commission (Z181100001718134)
Fundamental Research Funds for Central Universities of the Central South University (BMU2018MI015)
the Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases (BZ0317)
Article History
Received: 24 August 2022
Accepted: 12 November 2022
First Online: 6 December 2022
Declarations
:
: All authors declared no potential conflicts of interest.
: This retrospective study involves human participants following the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was reviewed and approved by the Ethics Committee Board of Peking University First Hospital (approval number: 2021 [009]).
: This research study was conducted retrospectively from data obtained for clinical and quality monitoring purposes. The use of this de-identified dataset in this study was approved by the Ethics Committee Board of Peking University First Hospital with a waiver of informed consent.
: This retrospective study used a de-identified dataset. Consent to publish from participants could not be applied in this study.
: Software: SAS software 9.4 (SAS Inc., Cary, NC, USA), RRID: SCR_008567.